No Data
Hong Kong stock concept tracking | The end of medical insurance negotiations is very encouraging for innovative drugs to be included in medical insurance at reasonable prices (with concept stocks)
The on-site negotiation and bidding stages for the adjustment of the national medical insurance pharmaceutical catalog in 2024 officially ended recently.
Historically the most 'competitive'? The Tenth Batch of National Procurement Pharmaceutical Catalog Is Officially Announced with one type having up to 31 companies competing.
①This afternoon, the National Pharmaceutical Joint Procurement Office officially announced the tenth batch of nationally purchased pharmaceutical catalog, with a total of 263 specifications and 62 varieties; ②Several industry insiders have stated that the tenth batch of national procurement will be the largest and most competitive national procurement in history.
zheshang: Continuous realization of technological innovation upgrade driving the continuous improvement of performance expectations for innovative drugs and industry chain.
The commercialization period of innovative drugs in the industry chain, driven purely by incremental value, is entering the phase of realization. The scarce incremental prosperity of the pharmaceutical sector continues to rise, with increasing international competitiveness, and there is still room for upward valuation.
Hong Kong healthcare stocks receive attention from investors again, with Trifolium Biotech surging nearly 15%.
①What is the impact of medical insurance negotiations on pharmaceutical stocks? ②What are the reasons for the rise of Tri Clover Biopharmaceutical and Yimington Corporation?
Intelligent Hong Kong Stock Shareholder Equity Disclosure | October 22
Hong Kong shareholder equity disclosure | October 22
ssy group (02005.HK) announced that the executive director, chairman, and CEO, Qu Jiguang, increased his shareholding by 0.8 million shares.
According to the latest equity disclosure information from the Hong Kong Stock Exchange on October 22, 2024, ssy group (02005.HK) saw executive director, chairman, and CEO Qu Jiguang increase his shareholding by an average of 3.8977 Hong Kong dollars per share to acquire 0.8 million shares on October 21, 2024, totaling approximately 3.1182 million Hong Kong dollars. Following the shareholding increase, Qu Jiguang's latest number of shares held is 1,137,406,000 shares, and his shareholding percentage has increased from 38.42% to 38.45%.
Earnings Are Growing at SSY Group (HKG:2005) but Shareholders Still Don't Like Its ProspectsNo Data
No Data
